{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:35:25Z","timestamp":1794040525507,"version":"4.8.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270629"],"award-info":[{"award-number":["82270629"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Henan Provincial Science Fund for Distinguished Young Scholars, China","award":["232300421011"],"award-info":[{"award-number":["232300421011"]}]},{"name":"Health Science and Technology Innovation Fund for Distinguished Young Scholars, Health Commission of Henan Province, China","award":["YXKC2020024"],"award-info":[{"award-number":["YXKC2020024"]}]},{"name":"Program for Science & Technology Innovation Talents in Universities of Henan Province, China","award":["24HASTIT064"],"award-info":[{"award-number":["24HASTIT064"]}]},{"name":"Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University, China","award":["QNCXTD2023014"],"award-info":[{"award-number":["QNCXTD2023014"]}]},{"name":"Young and Middle-aged Academic Leaders of Health Commission of Henan Province, China","award":["HNSWJW-2023029"],"award-info":[{"award-number":["HNSWJW-2023029"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09723-0","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T10:02:20Z","timestamp":1723716140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study"],"prefix":"10.1186","volume":"24","author":[{"given":"Qing-Lei","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Jiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"issue":"10","key":"9723_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"Polaris Observatory Collaborators","year":"2023","unstructured":"Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879\u2013907.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"9723_CR2","doi-asserted-by":"publisher","first-page":"e3324","DOI":"10.1093\/cid\/ciaa1939","volume":"73","author":"QL Zeng","year":"2021","unstructured":"Zeng QL, Yu ZJ, Ji F, Li GM, Zhang GF, Xu JH, et al. Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective. Observational Study Clin Infect Dis. 2021;73(9):e3324\u201332.","journal-title":"Observational Study Clin Infect Dis"},{"key":"9723_CR3","unstructured":"Zeng QL, Zhang HX, Zhang JY, Huang S, Li WZ, Li GM, et al. Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study. Clin Gastroenterol Hepatol. 2022;20(12):2826\u201337 e2829."},{"issue":"1","key":"9723_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12072-022-10415-7","volume":"17","author":"M Li","year":"2023","unstructured":"Li M, Li Q, Qu J, Yang H, Lv T, Kong Y, Zhang H. The effectiveness of combination therapy with interferon and nucleoside analogs in pediatric patients with chronic hepatitis B: a systematic review and meta-analysis. Hepatol Int. 2023;17(1):52\u201362.","journal-title":"Hepatol Int"},{"key":"9723_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpeds.2021.05.035","volume":"237","author":"SC Ling","year":"2021","unstructured":"Ling SC, Lin HS, Murray KF, Rosenthal P, Mogul D, Rodriguez-Baez N, et al. Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada. J Pediatr. 2021;237:24-33 e12.","journal-title":"J Pediatr"},{"issue":"6","key":"9723_CR6","first-page":"1425","volume":"11","author":"H You","year":"2023","unstructured":"You H, Wang FS, Li TS, Xu XY, Sun YM, Nan YM, et al. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022). J Clin Transl Hepatol. 2023;11(6):1425\u201342.","journal-title":"J Clin Transl Hepatol"},{"issue":"9796","key":"9723_CR7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(11)61460-8","volume":"378","author":"T Yang","year":"2011","unstructured":"Yang T, Wu MC. Discrimination against hepatitis B carriers in China. Lancet. 2011;378(9796):1059.","journal-title":"Lancet"},{"issue":"3","key":"9723_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cgh.2019.08.033","volume":"18","author":"TC Yip","year":"2020","unstructured":"Yip TC, Lok AS. How Do We Determine Whether a Functional Cure for HBV Infection Has Been Achieved? Clin Gastroenterol Hepatol. 2020;18(3):548\u201350.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"9723_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1\u201398.","journal-title":"Hepatol Int"},{"issue":"7","key":"9723_CR10","first-page":"487","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi. 2009;47(7):487\u201392.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"6","key":"9723_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/hep.1840130605","volume":"13","author":"M Ruiz-Moreno","year":"1991","unstructured":"Ruiz-Moreno M, Rua MJ, Molina J, Moraleda G, Moreno A, Garcia-Aguado J, Carreno V. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Hepatology. 1991;13(6):1035\u20139.","journal-title":"Hepatology"},{"issue":"5","key":"9723_CR12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0016-5085(98)70318-X","volume":"114","author":"EM Sokal","year":"1998","unstructured":"Sokal EM, Conjeevaram HS, Roberts EA, Alvarez F, Bern EM, Goyens P, et al. Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology. 1998;114(5):988\u201395.","journal-title":"Gastroenterology"},{"issue":"3","key":"9723_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jpeds.2004.05.046","volume":"145","author":"GE Kobak","year":"2004","unstructured":"Kobak GE, MacKenzie T, Sokol RJ, Narkewicz MR. Interferon treatment for chronic hepatitis B: enhanced response in children 5 years old or younger. J Pediatr. 2004;145(3):340\u20135.","journal-title":"J Pediatr"},{"issue":"5","key":"9723_CR14","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/hep.30050","volume":"68","author":"S Wirth","year":"2018","unstructured":"Wirth S, Zhang H, Hardikar W, Schwarz KB, Sokal E, Yang W, et al. Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study. Hepatology. 2018;68(5):1681\u201394.","journal-title":"Hepatology"},{"issue":"6","key":"9723_CR15","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/hep.30312","volume":"69","author":"P Rosenthal","year":"2019","unstructured":"Rosenthal P, Ling SC, Belle SH, Murray KF, Rodriguez-Baez N, Schwarzenberg SJ, et al. Combination of Entecavir\/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection. Hepatology. 2019;69(6):2326\u201337.","journal-title":"Hepatology"},{"issue":"2","key":"9723_CR16","doi-asserted-by":"publisher","first-page":"e005","DOI":"10.1097\/PG9.0000000000000005","volume":"1","author":"H Komatsu","year":"2020","unstructured":"Komatsu H, Inui A, Yoshio S, Kanto T, Umetsu S, Tsunoda T, Fujisawa T. High Dose of Pegylated Interferon for the Treatment of Chronic Hepatitis B in Children Infected With Genotype C. JPGN Rep. 2020;1(2):e005.","journal-title":"JPGN Rep"},{"issue":"6","key":"9723_CR17","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jhep.2018.01.037","volume":"68","author":"S Zhu","year":"2018","unstructured":"Zhu S, Zhang H, Dong Y, Wang L, Xu Z, Liu W, et al. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study. J Hepatol. 2018;68(6):1123\u20138.","journal-title":"J Hepatol"},{"issue":"7","key":"9723_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.14309\/ajg.0000000000002125","volume":"118","author":"NA Terrault","year":"2023","unstructured":"Terrault NA, Lok AS, Wahed AS, Ghany MG, Perrillo RP, Fried MW, et al. Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B. Am J Gastroenterol. 2023;118(7):1214\u201325.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"9723_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12072-023-10631-9","volume":"18","author":"M Zhang","year":"2024","unstructured":"Zhang M, Li J, Xu Z, Fan P, Dong Y, Wang F, et al. Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B. Hepatol Int. 2024;18(2):435\u201348.","journal-title":"Hepatol Int"},{"issue":"3","key":"9723_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S2468-1253(16)30107-8","volume":"1","author":"M Buti","year":"2016","unstructured":"Buti M, Gane E, Seto WK, Chan HL, Chuang WL, Stepanova T, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol. 2016;1(3):196\u2013206.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"9723_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2468-1253(16)30024-3","volume":"1","author":"HL Chan","year":"2016","unstructured":"Chan HL, Fung S, Seto WK, Chuang WL, Chen CY, Kim HJ, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol. 2016;1(3):185\u201395.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"9723_CR22","doi-asserted-by":"crossref","unstructured":"Cathcart AL, Chan HL, Bhardwaj N, Liu Y, Marcellin P, Pan CQ, et al. No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection. Antimicrob Agents Chemother. 2018; 62(10).","DOI":"10.1128\/AAC.01064-18"},{"key":"9723_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.04.015","volume":"119","author":"E De Clercq","year":"2016","unstructured":"De Clercq E. Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF). Biochem Pharmacol. 2016;119:1\u20137.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"9723_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12519-019-00303-w","volume":"15","author":"Y Hu","year":"2019","unstructured":"Hu Y, Ye YZ, Ye LJ, Wang XH, Yu H. Efficacy and safety of interferon alpha-2b versus pegylated interferon alpha-2a monotherapy in children with chronic hepatitis B: a real-life cohort study from Shanghai. China World J Pediatr. 2019;15(6):595\u2013600.","journal-title":"China World J Pediatr"},{"issue":"6","key":"9723_CR25","doi-asserted-by":"publisher","first-page":"ofaa208","DOI":"10.1093\/ofid\/ofaa208","volume":"7","author":"QL Zeng","year":"2020","unstructured":"Zeng QL, Yu ZJ, Shang J, Xu GH, Sun CY, Liu N, et al. Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels. Open Forum Infect Dis. 2020;7(6):ofaa208.","journal-title":"Open Forum Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09723-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09723-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09723-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T10:02:37Z","timestamp":1723716157000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09723-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9723"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09723-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"10 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2008. Written informed consent was obtained from the parents before the initiation of the treatment. This study was approved by the ethics committee of The First Affiliated Hospital of Zhengzhou University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all the parents of the children.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"830"}}